JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. reported 2 transactions at KAILERA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/22/2026ACC: 0001104659-26-046276
→
10% Owner
Since Apr 2026
+5.83M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
11.51M acquired · 5.68M disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+9.48M
Price / share
—
Trade value
—
% of position
New position
4/20/2026
0.00→9.48M
Common Stock
Direct
Shares
+2.03M
Price / share
—
Trade value
—
% of position
New position
4/20/2026
0.00→2.03M
Total
Net shares
+11.51M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/20/2026 | C · Conversion | +9.48M | — | — | New position | 0.00 | 9.48M |
| Common Stock Direct | 4/20/2026 | C · Conversion | +2.03M | — | — | New position | 0.00 | 2.03M |
| Total | +11.51M | $0.00 | ||||||
Derivative Transactions2
Series A-2 convertible preferred stock
Direct
Converts to
Common Stock
9.48M shares
Shares
−4.97M
Strike price
Held after
0.00
Exercisable
—
4/20/2026
Series A-2 convertible non-voting preferred stock
Direct
Converts to
Common Stock
2.03M shares
Shares
−708.81K
Strike price
Held after
0.00
Exercisable
—
4/20/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A-2 convertible preferred stock Direct | Common Stock9.48M shares | 4/20/2026 | C · Conversion | −4.97M | — | 0.00 | |
| Series A-2 convertible non-voting preferred stock Direct | Common Stock2.03M shares | 4/20/2026 | C · Conversion | −708.81K | — | 0.00 |
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.00
Total
1.00 indirect1.00
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.00 | Indirect |
| Total | 1.00 | 1.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported